Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

Clinical trial condition

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

Explore clinical trials studying Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk trial results

Not Yet Recruiting

A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

NCT07682272

Conditions: Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details